The present invention is directed to compounds of the formula I: I (wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, X, Z and n are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2. ##STR00001##

 
Web www.patentalert.com

< Method of therapeautic treatments including human immunodeficiency virus (HIV) disease and other conditions in a human host by administering adenine nucleotides

> N-(3,4-disubstituted phenyl) salicylamide derivatives

> Azaindoles useful as inhibitors of rock and other protein kinases
~ 00510